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Several classiﬁcations systems have been developed to predict outcomes of kidney
transplantation based on donor variables.
This study aims to identify kidney transplant recipient variables that would predict graft
outcome irrespective of donor characteristics.
All U.S. kidney transplant recipients between October 25,1999 and January 1, 2007
were reviewed. Cox proportional hazards regression was used to model time until graft
failure. Death-censored and nondeath-censored graft survival models were generated
for recipients of live and deceased donor organs. Recipient age, gender, body mass
index (BMI), presence of cardiac risk factors, peripheral vascular disease, pulmonary
disease, diabetes, cerebrovascular disease, history of malignancy, hepatitis B core
antibody, hepatitis C infection, dialysis status, panel-reactive antibodies (PRA), geographic region, educational level, and prior kidney transplant were evaluated in all
kidney transplant recipients.
Among the 88,284 adult transplant recipients the following groups had increased risk of
graft failure: younger and older recipients, increasing PRA (hazard ratio [HR],1.03–
1.06], increasing BMI (HR, 1.04–1.62), previous kidney transplant (HR, 1.17–1.26),
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dialysis at the time of transplantation (HR, 1.39–1.51), hepatitis C infection (HR, 1.41–
1.63), and educational level (HR, 1.05–1.42).
Predictive criteria based on recipient characteristics could guide organ allocation, risk
stratiﬁcation, and patient expectations in planning kidney transplantation.

Kidney transplantation represents the best alternative for
survival and improved quality of life for eligible end stage
renal disease patients. Although several classiﬁcations that
estimate outcomes have been developed, they all involve
donor features. The Kidney Donor Risk Index (KDRI) and
Kidney Donor Proﬁle Index (KDPI),1,2 based on deceased
donor age, height, weight, ethnicity, history of hypertension,
history of diabetes, cause of death, serum creatinine, hepatitis
C virus status, and donation after circulatory death, assess the
relative risk of graft failure irrespective of recipient
characteristics.
The objective of this study was to identify kidney transplant recipient variables that would predict graft outcome
irrespective of donor characteristics. These recipient predictive criteria could constitute an instrument of great potential
value and a relevant addition to the current allocation system.
They would provide information on expected outcomes not
only at the time of evaluation and during wait listing when no
donor information is routinely available, but also at the time
of organ allocation when they would be complemented by the
already existing donor classiﬁcations.

Methods
Subjects
Data on 88,284 kidney transplants performed in the United
States from October 25, 1999 to January 1, 2007 obtained
from the United Network for Organ Sharing (UNOS) were
considered in the analysis.

Selection Criteria
There were 119,979 transplants between October 25, 1999
and January 1, 2007. Several variables of interest (drugtreated hypertension, cerebrovascular disease, and angina)
had collection end dates of January 1, 2007. Since then, they
have become optional data ﬁelds and their reporting has been
sparse. The start date was chosen because relevant donorrelated variables (deceased donor  cardiac arrest post–
brain death), although not of primary interest, had collection
dates beginning October 25, 1999. Recipients listed for pancreas (n ¼ 3,629) and kidney pancreas (n ¼ 6,719) as well as
those with no organ listed (n ¼ 16,173) were excluded.
Kidney recipients younger than 18 or with missing age
were also excluded (n ¼ 3,857). There were 1,317 adult
kidney recipients with multiple transplants in our timeframe
of interest. For purposes of our analysis, only the initial
transplant between October 25, 1999 and January 1, 2007
was included. Body mass index (BMI) < 15 or > 55, live
donor preoperative creatinine > 1.5, and deceased donor
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terminal creatinine > 6 were deemed unlikely and treated
as unknown.

Primary Outcome Variable
The primary outcome considered was (death-censored and
nondeath-censored) graft survival, as deﬁned in previous
studies.3 In death-censored graft survival, graft survival
was censored at the time of death (based on the assumption
that death was unrelated to the transplant) or at the time of
the last known patient status (if neither failure nor death
occurred). In nondeath-censored graft survival, death with a
functioning graft was treated as graft failure (under the
assumption that death was related to the transplant).

Statistical Analysis
Cox regression was used to model time until graft failure.
Recipient risk factors signiﬁcantly associated with graft failure using univariable screening at the level of p < 0.10 were
included in the ﬁnal multivariable model. Transplant and
donor variables known to be highly predictive of graft failure,
while not of direct interest, were included in the multivariable model as covariates, regardless of statistical signiﬁcance.
Donor variables included human leukocyte antigen (HLA)
mismatch and elements of the KDPI. Although backward
elimination was also considered in building the ﬁnal model,
its results were similar to those of univariable screening and
are not reported here. Separate models were used for recipients of live and deceased donors. Each model was analyzed
using both deﬁnitions of graft survival, resulting in four
multivariable models. The proportional hazards assumption
was evaluated graphically by plotting the log-negative-log of
the estimated survival function by the log of time.

Results
Demographics of the 88,284 subjects included in our ﬁnal
sample are detailed in ►Table 1.

Death-Censored Graft Survival
Recipients of Live Donors
►Table 2 shows the death-censored multivariable Cox regression analysis for graft survival in recipients of live donors
(3,667 graft failures). Younger and older recipients (quadratic
term) had an increased risk of graft failure. Recipients with
overweight or obese BMI, a previous kidney transplant,
hepatitis C, increasing panel-reactive antibodies (PRA), dialysis at the time of transplant, and diabetes also had an
increased risk of graft failure as compared to recipients
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Table 1 Characteristics of kidney transplant recipients of live and deceased donors and all recipients
Factor

All recipients
(n ¼ 88,284)

Recipients of live donors
(n ¼ 27,117)

Recipients of deceased
donors (n ¼ 61,167)

Age, y

48.90  13.26

46.03  13.39

50.17  13.00

53,174 (60.23)

16,064 (59.24)

37,110 (60.67)

Underweight, no. (%)

2,432 (2.75)

775 (2.86)

1,657 (2.71)

Normal weight, no. (%)

31,722 (35.93)

9,954 (36.71)

21,768 (35.59)

Overweight, no. (%)

28,464 (32.24)

8,677 (32.00)

19,787 (32.35)

Obese class I, no. (%)

15,349 (17.39)

4,648 (17.14)

10,701 (17.49)

Obese class II, no. (%)

4,998 (5.66)

1,491 (5.50)

3,507 (5.73)

Obese class III, no. (%)

1,497 (1.70)

476 (1.76)

1,021 (1.67)

Unknown

3,822 (4.33)

1,096 (4.04)

2,726 (4.46)

Yes

9,467 (10.72)

2,528 (9.32)

6,939 (11.34)

No

78,817 (89.28)

24,589 (90.68)

54,228 (88.66)

Gender
Male no. (%)
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BMI

Previous kidney transplant

Previous malignancy
Yes

3,043 (3.45)

955 (3.52)

2,088 (3.41)

No

74,826 (84.76)

22,995 (84.80)

51,831 (84.74)

Unknown

10,415 (11.80)

3,167 (11.68)

7,428 (11.85)

Yes

8,684 (9.84)

2,378 (8.77)

6,306 (10.31)

No

74,075 (83.91)

22,922 (84.53)

51,153 (83.63)

Unknown

5,525 (6.26)

1,817 (6.70)

3,708 (6.06)

Yes

68,902 (78.05)

21,341 (78.70)

47,561 (77.76)

No

14,887 (16.86)

4,383 (16.16)

10,504 (17.17)

Unknown

4,495 (5.09)

1,393 (5.14)

3,102 (5.07)

2,981 (3.38)

837 (3.09)

2,144 (3.51)

Angina

Drug-treated hypertension

Peripheral vascular disease
Yes
No

79,144 (89.65)

24,368 (89.86)

54,776 (89.55)

Unknown

6,159 (6.98)

1,912 (7.05)

4,247 (6.94)

761 (0.86)

217 (0.80)

544 (0.89)

Drug-treated COPD
Yes
No

82,384 (93.32)

25,341 (93.45)

57,043 (93.26)

Unknown

5,139 (5.82)

1,559 (5.75)

3,580 (5.85)

Symptomatic cerebrovascular disease
Yes

2,046 (2.32)

560 (2.07)

1,486 (2.43)

No

80,551 (91.24)

24,899 (91.82)

55,652 (90.98)

Unknown

5,687 (6.44)

1,658 (6.11)

4,029 (6.59)

Positive

1,475 (1.67)

395 (1.46)

1,080 (1.77)

Negative

75,098 (85.06)

23,451 (86.48)

51,647 (84.44)

Not done

1,949 (2.21)

562 (2.07)

1,387 (2.27)

Unknown/missing

9,762 (11.06)

2,709 (9.99)

7,053 (11.53)

Hepatitis B surface antigen

(Continued)
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Table 1 (Continued)
Factor

All recipients
(n ¼ 88,284)

Recipients of live donors
(n ¼ 27,117)

Recipients of deceased
donors (n ¼ 61,167)

Hepatitis C status
Positive

4,875 (5.52)

799 (2.95)

4,076 (6.66)

Negative

72,795 (82.46)

23,554 (86.86)

49,241 (80.50)

Not done

6,253 (7.08)

1,592 (5.87)

4,661 (7.62)

Unknown/missing

4,361 (4.94)

1,172 (4.32)

3,189 (5.21)

Yes

74,094 (83.93)

19,780 (72.94)

54,314 (88.80)

No

12,899 (14.61)

6,839 (25.22)

6,060 (9.91)

Unknown

1,291 (1.46)

498 (1.84)

793 (1.30)

Yes

25,270 (28.62)

7,144 (26.35)

18,126 (29.63)

No

61,130 (69.24)

19,434 (71.67)

41,696 (68.17)

Unknown

1,884 (2.13)

539 (1.99)

1,345 (2.20)

0.0 (0.0, 0.0)

0.00 (0.00, 3.00)

Dialysis at transplant

Diabetes at registration

Current PRA (median [Q1, Q3])
Education
No high school diploma or GED

4,765 (5.40)

994 (3.67)

3,771 (6.17)

High school diploma or GED

33,091 (37.48)

9,114 (33.61)

23,977 (39.20)

Attended college/technical school

17,389 (19.70)

5,951 (21.95)

11,438 (18.70)

Associate/bachelor’s degree

10,811 (12.25)

4,176 (15.40)

6,635 (10.85)

Graduate degree

4,291 (4.86)

1,831 (6.75)

2,460 (4.02)

Unknown/missing

17,937 (20.32)

5,051 (18.63)

12,886 (21.07)

Region
1

3,722 (4.22)

1,202 (4.43)

2,520 (4.12)

2

13,544 (15.34)

4,472 (16.49)

9,072 (14.83)

3

11,145 (12.62)

2,512 (9.26)

8,633 (14.11)

4

7,443 (8.43)

1,865 (6.88)

5,578 (9.12)

5

14,055 (15.92)

4,976 (18.35)

9,079 (14.84)

6

2,960 (3.35)

628 (2.32)

2,332 (3.81)

7

9,398 (10.65)

3,757 (13.85)

5,641 (9.22)

8

4,944 (5.60)

1,463 (5.40)

3,481 (5.69)

9

5,579 (6.32)

1,819 (6.71)

3,760 (6.15)

10

7,567 (8.57)

2,371 (8.74)

5,196 (8.49)

11

7,927 (8.98)

2,052 (7.57)

5,875 (9.60)

Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; GED, general educational development; PRA, panel-reactive
antibodies.

without these characteristics. Recipients with a high school
(HS) diploma or general educational development (GED) had
an increased risk of graft failure as compared to attendees of
college, recipients of associate or bachelor’s degrees and
graduate degrees, with hazard ratio (HR) ranging from 1.14
to 1.42. Attendees of college had an increased risk of graft
failure as compared to recipients of associate or bachelor’s
degrees (HR,1.13) and graduate degrees. Recipients in UNOS
International Journal of Angiology
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transplant region 2 had an increased risk of graft failure as
compared to regions 1, 3, 4, 5, and 10, with HR ranging from
1.20 to 1.27. Malignancy, angina, drug-treated hypertension,
drug-treated chronic obstructive pulmonary disease (COPD),
peripheral vascular disease, and cerebral vascular disease
were not statistically signiﬁcant at p < 0.10 by univariable
screen and were excluded from the ﬁnal multivariable
model.
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Table 2 Death-censored graft survival in recipients of live donors and recipients of deceased donors
Factora

Recipients of live donorsb,c
HR (95% CI)
n ¼ 27,117

Recipients of deceased donorsd,e
HR (95% CI)
n ¼ 61,167

Age

0.93 (0.92, 0.95)

0.94 (0.93, 0.94)

Age age

1.01 (1.00, 1.01)

1.00 (1.00, 1.01)

Male

0.97 (0.91, 1.04)

1.07 (1.03, 1.11)

Female

Reference

Reference

Underweight

1.05 (0.87, 1.26)

0.95 (0.85, 1.05)

Normal weight

Reference

Reference

Overweight

1.09 (1.00, 1.18)

1.11 (1.07, 1.16)

Obese class I

1.26 (1.14, 1.39)

1.27 (1.20, 1.33)

Obese class II

1.47 (1.28, 1.68)

1.37 (1.27, 1.47)

Obese class III

1.62 (1.32, 1.99)

1.61 (1.43, 1.82)

Yes

1.25 (1.13, 1.39)

1.17 (1.11, 1.24)

No

Reference

Reference

Gender
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BMI

Previous kidney transplant

Peripheral vascular disease
Yes

1.13 (1.02, 1.25)

No

Reference

Hepatitis C status
Positive

1.56 (1.33, 1.83)

1.44 (1.34, 1.54)

Negative

Reference

Reference

Not done

0.90 (0.75, 1.08)

1.04 (0.96, 1.13)

Yes

1.43 (1.31, 1.56)

1.51 (1.41, 1.62)

No

Reference

Reference

Yes

1.09 (1.00, 1.18)

1.02 (0.98, 1.06)

No

Reference

Current PRA (in 10-percentage point increments)

1.06 (1.04, 1.08)

1.04 (1.03, 1.05)

No high school diploma or GED

1.33 (1.04, 1.70)

1.00 (0.89, 1.13)

High school diploma or GED

1.42 (1.20, 1.66)

1.12 (1.01, 1.23)

Attended college/technical school

1.24 (1.05, 1.47)

1.06 (0.96, 1.18)

Associate/bachelor’s degree

1.09 (0.92, 1.31)

1.02 (0.92, 1.14)

Graduate degree

Reference

Reference

1

1.03 (0.86, 1.23)

1.07 (0.97, 1.19)

2

1.27 (1.11, 1.45)

1.37 (1.28, 1.47)

3

1.06 (0.91, 1.23)

1.12 (1.04, 1.21)

4

1.03 (0.87, 1.21)

1.18 (1.09, 1.28)

5

Reference

Reference

6

1.00 (0.78, 1.29)

0.94 (0.84, 1.05)

Dialysis at transplant

Diabetes

Education

Region

(Continued)
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Table 2 (Continued)
Factora

Recipients of live donorsb,c
HR (95% CI)
n ¼ 27,117

Recipients of deceased donorsd,e
HR (95% CI)
n ¼ 61,167

7

1.16 (1.02, 1.33)

1.11 (1.02, 1.20)

8

1.17 (0.99, 1.38)

1.05 (0.95, 1.15)

9

1.08 (0.90, 1.29)

1.27 (1.17, 1.39)

10

1.06 (0.91, 1.23)

1.13 (1.04, 1.22)

11

1.15 (0.99, 1.33)

1.35 (1.26, 1.46)

Abbreviations: BMI, body mass index; CI, conﬁdence interval; COPD, chronic obstructive pulmonary disease; GED, general educational development;
HR, hazard ratio; PRA, panel-reactive antibodies.
a
Recipients of live/deceased donors: Unknown or missing categories are not presented in the table since valid inferences cannot be drawn from them.
b
Recipients of live donors: Model is also adjusted for recipient hepatitis B surface antigen. However, the results are not displayed due to nonsigniﬁcance
in the multivariable model.
c
Recipients of live donors: Model is also adjusted for donor age, donor BMI, donor gender, donor ethnicity, HLA mismatch level, donor preoperative
creatinine, and donor hepatitis C antibody.
d
Recipients of deceased donors: Model is also adjusted for recipient angina status, cerebrovascular disease, and hepatitis B surface antigen. However,
the results are not displayed due to nonsigniﬁcance in the multivariable model.
e
Recipients of deceased donors: Model is also adjusted for donor age, donor BMI, donor gender, donor ethnicity, HLA mismatch level, donor terminal
laboratory creatinine, donor hepatitis C antibody, donor history of diabetes, donor history of hypertension, donor cause of death, and donor cardiac
arrest postbrain death.

Recipients of Deceased Donors
►Table 2 shows the death-censored multivariable Cox regression analysis for graft survival in recipients of deceased
donors (13,361 graft failures). Younger and older recipients
had an increased risk of graft failure. Males, recipients with
overweight or obese BMI, a previous kidney transplant,
peripheral vascular disease, hepatitis C, increasing PRA, and
dialysis at the time of transplant also had an increased risk
of graft failure as compared to recipients without these
characteristics. Recipients with a HS diploma or GED had
an increased risk of graft failure as compared to recipients
without a HS diploma, attendees of college, recipients of
associate or bachelor’s degrees, and graduate degrees, with
HR ranging from 1.05 to 1.12. Region 5 and 6 recipients had
a reduced risk of graft failure as compared to all other
regions, excluding region 8, with HR ranging from 0.68 to
0.90. Region 2 recipients had an increased risk of graft
failure as compared to all other regions, excluding 9 and 11,
with HR ranging from 1.16 to 1.46. Region 9 recipients had
an increased risk of graft failure as compared to regions 1,
3, 5, 6, 7, 8, and 10, with HR ranging from 1.13 to 1.36.
Malignancy, drug-treated hypertension, and drug-treated
COPD were not statistically signiﬁcant at p < 0.10 by univariable screen and were excluded from the ﬁnal multivariable model.

Nondeath-Censored Graft Survival
Recipients of Live Donors
►Table 3 shows the noncensored multivariable Cox regression graft survival analysis for recipients of live donors (6,026
graft failures, inclusive of recipients who died with functioning grafts). Younger and older recipients had an increased risk
of graft failure. Recipients with underweight or obese BMI, a
previous kidney transplant, malignancy, drug-treated COPD,
International Journal of Angiology
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angina, peripheral vascular disease, cerebral vascular disease,
hepatitis C, increasing PRA, dialysis at the time of transplant,
and diabetes also had an increased risk of graft failure as
compared to recipients without these characteristics. Recipients without a HS diploma or GED had an increased risk of
graft failure as compared to recipients of associate or bachelor’s degrees (HR,1.22) and graduate degrees. Recipients
with a HS diploma or GED had an increased risk of graft
failure as compared to attendees of college, recipients of
associate or bachelor’s degrees, and graduate degrees with
HR ranging from 1.11 to 1.36. Attendees of college had an
increased risk of graft failure as compared to recipients of
associate or bachelor’s degrees (HR,1.14) and graduate degrees. Gender was not statistically signiﬁcant at p < 0.10 by
univariable screen and was excluded from the ﬁnal multivariable model.

Recipients of Deceased Donors
►Table 3 shows the noncensored multivariable Cox regression graft survival analysis for recipients of deceased donors
(23,231 graft failures inclusive of patients who died with a
functioning graft). Younger and older recipients had an
increased risk of graft failure. Males and recipients with
overweight or obese BMI, a previous kidney transplant,
malignancy, angina, peripheral vascular disease, hepatitis C,
increasing PRA, dialysis at the time of transplant, and diabetes
also had an increased risk of graft failure as compared to
recipients without these characteristics. Recipients with a HS
diploma or GED had an increased risk of graft failure as
compared to attendees of college, recipients of associate or
bachelor’s degrees and graduate degrees, with HR ranging
from 1.06 to 1.15. Attendees of college had an increased risk of
graft failure as compared to recipients of associate or bachelor’s degrees (HR,1.08) and graduate degrees. Recipients
from regions 5, 6, and 8 had a reduced risk of graft failure

This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.

34

Kidney Transplant Recipient Predictors

Molmenti et al.

35

Table 3 Nondeath-censored graft survival in recipients of live donors and recipients of deceased donors
Factora

Recipients of live donorsb,c
HR (95% CI)
n ¼ 27,117

Recipients of deceased donorsd,e
HR (95% CI)
n ¼ 61,167

Age

0.92 (0.91, 0.93)

0.93 (0.93, 0.94)

Age age

1.01 (1.00, 1.01)

1.00 (1.00, 1.01)

Gender
Male

1.12 (1.09, 1.15)

Female

Reference

Underweight

1.19 (1.02, 1.38)

1.07 (0.98, 1.16)

Normal weight

Reference

Reference

Overweight

1.01 (0.95, 1.08)

1.04 (1.01, 1.07)

Obese class I

1.10 (1.02, 1.38)

1.17 (1.12, 1.21)

Obese class II

1.32 (1.18, 1.47)

1.21 (1.14, 1.28)

Obese class III

1.46 (1.23, 1.73)

1.54 (1.40, 1.69)

Yes

1.26 (1.15, 1.37)

1.19 (1.14, 1.24)

No

Reference

Reference

Yes

1.28 (1.13, 1.44)

1.10 (1.03, 1.18)

No

Reference

Reference

Yes

1.54 (1.24, 1.92)

1.10 (0.97, 1.25)

No

Reference

Reference

Yes

1.11 (1.02, 1.21)

1.18 (1.13, 1.23)

No

Reference

Reference

Yes

1.27 (1.12, 1.43)

1.30 (1.22, 1.38)

No

Reference

Reference

Yes

1.21 (1.04, 1.41)

1.05 (0.97, 1.14)

No

Reference

Reference

Positive

1.63 (1.44, 1.84)

1.41 (1.33, 1.49)

Negative

Reference

Reference

Not done

0.95 (0.82, 1.10)

1.02 (0.95, 1.08)

Yes

1.46 (1.36, 1.56)

1.39 (1.32, 1.46)

No

Reference

Reference

Yes

1.42 (1.34, 1.50)

1.32 (1.28, 1.36)

No

Reference

Reference

Current PRA (in 10-percentage point increments)

1.05 (1.04, 1.07)

1.03 (1.03, 1.04)
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BMI

Previous kidney transplant

Malignancy

Drug-treated COPD

Angina

Peripheral vascular disease

Cerebral vascular disease

Hepatitis C status

Dialysis at transplant

Diabetes

Education
(Continued)
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Table 3 (Continued)
Factora

Recipients of live donorsb,c
HR (95% CI)
n ¼ 27,117

Recipients of deceased donorsd,e
HR (95% CI)
n ¼ 61,167

No high school diploma or GED

1.32 (1.10, 1.57)

1.05 (0.97, 1.15)

High school diploma or GED

1.36 (1.21, 1.53)

1.15 (1.07, 1.23)

Attended college/technical school

1.23 (1.09, 1.39)

1.08 (1.01, 1.17)

Associate/bachelor’s degree

1.08 (0.95, 1.23)

1.00 (0.93, 1.09)

Graduate degree

Reference

Reference

Region
1

1.04 (0.91, 1.20),

1.07 (0.99, 1.15)

2

1.18 (1.07, 1.31)

1.22 (1.16, 1.29)

3

1.09 (0.97, 1.23)

1.13 (1.07, 1.19)

4

0.98 (0.80, 1.19)

1.16 (1.10, 1.23)

5

Reference

Reference

6

0.98 (0.80, 1.19)

0.97 (0.90, 1.06)

7

1.11 (1.00, 1.23)

1.13 (1.06, 1.20)

8

1.09 (0.95, 1.24)

1.05 (0.98, 1.12)

9

1.07 (0.93, 1.23)

1.18 (1.11, 1.26)

10

1.08 (0.97, 1.21)

1.16 (1.10, 1.24)

11

1.20 (1.07, 1.34)

1.27 (1.20, 1.35)

Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; CI, conﬁdence interval; GED, general educational development;
HR, hazard ratio; PRA, panel-reactive antibodies.
a
Recipients of live/deceased donors: Unknown or missing categories are not presented in the table since valid inferences cannot be drawn from them.
b
Recipients of live donors: Model is also adjusted for recipient drug-treated hypertension and hepatitis B surface antigen. However, the results are not
displayed due to nonsigniﬁcance in the multivariable model or signiﬁcance in the unknown category.
c
Recipients of live donors: Model is also adjusted for donor age, donor BMI, donor gender, donor ethnicity, HLA mismatch level, donor preoperative
creatinine, and donor hepatitis C antibody.
d
Recipients of deceased donors: Model is also adjusted for recipient drug-treated hypertensionand hepatitis B surface antigen. However, the results
are not displayed due to nonsigniﬁcance in the multivariable model or signiﬁcance in the unknown category.
e
Recipients of deceased donors: Model is also adjusted for donor age, donor BMI, donor gender, donor ethnicity, HLA mismatch level, donor terminal
laboratory creatinine, donor hepatitis C antibody, donor history of diabetes, donor history of hypertension, donor cause of death, and donor cardiac
arrest postbrain death.

compared to all other regions, excluding 1, with HR ranging
from 0.76 to 0.93. Recipients from region 2 had an increased
risk of graft failure compared to regions 1, 3, 5, 6, 7, and 8, with
HR ranging from 1.08 to 1.26. Recipients from region 11 had
an increased risk of graft failure compared to all other regions,
excluding 2, with HR ranging from 1.08 to 1.31. All variables
were statistically signiﬁcant at p < 0.10 by univariable screen
and all were included in the ﬁnal multivariable model.

Discussion
Our series identiﬁed recipient age, increasing PRA, BMI, prior
transplant, dialysis at the time of transplantation, hepatitis C
infection, and education as variables associated with increased risk for graft failure in adult kidney transplant
recipients regardless of survival deﬁnition or donor type.
Younger and elderly recipients had an increased risk of
graft failure. A higher degree of immune responsiveness,
immunosuppressive medication noncompliance, ﬁnancial,
and social factors have been postulated to contribute to a
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greater incidence of early graft loss in the young.4–6 Previous
studies reported elderly recipients to have a high incidence of
comorbidities, frailty, and death with functioning grafts, as
well as a greater impact of rejection on graft loss.7
PRA is an immunological test that quantiﬁes the percentage of the population against which an individual reacts via
preformed antibodies. Recipients with PRA  80% have a
higher risk of acute rejection leading to graft failure, and
are given additional points in the organ allocation
algorithm.8
BMI is a measure of body fat based on height and weight.9
Patients with BMI  30 (obese classes I, II, and III) had an
increased risk of graft failure when compared with those
with lower BMI. An analysis of adult renal transplant patients
registered in U.S. Renal Data System had demonstrated that
BMI < 18 and > 36 were associated with worse patient and
graft survival.10 Surgical-site infections, delayed graft function, prolonged hospitalization, acute rejection, and decreased overall graft survival had previously been found to
be more prevalent in obese individuals.11,12
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Conclusions
We propose a model based on the recipient characteristics,
and independent of donor variables. Age, increasing PRA,
BMI, prior transplant, dialysis at the time of transplantation,
hepatitis C infection, and education were found to be associated with an increased risk for graft failure in adult kidney
transplant recipients regardless of survival deﬁnition and
donor type. These recipient predictive criteria could further
optimize outcomes and organ allocation27 by providing information not only at the time of evaluation and during wait
listing when no donor information is routinely available, but
also at the time of organ allocation when they would be
complemented by the already existing donor grading
classiﬁcations.
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